EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
9,051,420
Share change
-107,068
Total reported value
$99,471,224
Price per share
$10.99
Number of holders
62
Value change
+$1,739,504
Number of buys
42
Number of sells
21

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q3 2025

As of 30 Sep 2025, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,051,420 shares. The largest 10 holders included RTW INVESTMENTS, LP, VANGUARD GROUP INC, Balyasny Asset Management L.P., Invesco Ltd., KENNEDY CAPITAL MANAGEMENT LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, WEXFORD CAPITAL LP, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, and Russell Investments Group, Ltd.. This page lists 62 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.